Viewing nowCombinationOlodipine 10/40 mg (Amlodipine, Olmesartan Medoxomil)
Amlodipine Besylate 13.888mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.

MFDS item code 201404895 · Approved 2014.10.24 · Insurance code 648103510
Treatment of essential hypertension not controlled with monotherapy
Amlodipine or Olmesartan Medoxomil is used when blood pressure is not adequately controlled in patients with essential hypertension. These drugs relax blood vessels, lower blood pressure, and reduce the workload on the heart. By managing blood pressure stably, they help decrease the risk of cardiovascular diseases. Therefore, they are effectively used in the treatment of essential hypertension.
Take 1 tablet once daily with water, with or without food. It is recommended that you take it at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or olmesartan medoxomil). However, if blood pressure is not controlled with monotherapy using an individual component, switching directly to this medicine may be considered. The maximum dose of this medicine is 10/40 milligrams. The maximum blood pressure-lowering effect occurs within 2 weeks after administration; therefore, adjust the dose at intervals of at least 2 weeks, taking the patient's blood pressure response into account. The recommended doses are as follows: - 5/20 milligrams: For patients whose blood pressure is not adequately controlled with monotherapy with amlodipine 5 milligrams or olmesartan medoxomil 20 milligrams. - 10/20 milligrams: For patients whose blood pressure is not adequately controlled with monotherapy with olmesartan medoxomil 20 milligrams. - 5/40 milligrams: For patients whose blood pressure is not adequately controlled with 5/20 milligrams. - 10/40 milligrams: For patients whose blood pressure is not adequately controlled with 5/40 milligrams. ○ Patients with renal impairment: This medicine has not been studied in patients with renal impairment. However, the maximum dose of olmesartan medoxomil for patients with mild to moderate renal impairment (creatine clearance 20-60mL/min) is 20 milligrams once daily. This medicine is not recommended for patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or patients on dialysis. Monitoring of potassium and creatinine levels is recommended in patients with moderate renal impairment. ○ Patients with reduced intravascular volume: In patients who may have reduced intravascular volume (e.g., patients taking diuretics, particularly those with renal impairment), it is recommended to start treatment at a low dose while monitoring their condition closely. ○ Patients with hepatic impairment: Use with caution in patients with mild to moderate hepatic impairment. The recommended initial dose of olmesartan medoxomil for patients with moderate hepatic impairment is 10 milligrams once daily, and the maximum dose is 20 milligrams once daily. In patients with hepatic impairment who are already receiving other antihypertensive drugs and/or diuretics, blood pressure and renal function should be monitored closely. This medicine should not be administered to patients with severe hepatic impairment. (See section 2, Patients who should not take this medicine, under Precautions for Use.) ○ Older adults: Generally, start treatment at a low dose. When adjusting the dose, consider the patient's renal or cardiac function and comorbidities. In older adults, blood pressure should be monitored closely and more frequently.
Pediatric patients under 18 years of age: Safety and efficacy have not been established.
This drug should not be used during pregnancy due to the potential for serious harm to the fetus during the second and third trimesters. Individuals with allergies to this drug or similar medications, pregnant or nursing women, those with severe liver disease or certain heart conditions, patients undergoing dialysis, those in a state of shock, or patients with specific types of diabetes should not take this medication. Patients with hypotension or a severe risk of rapid vascular dilation, as well as those with severe heart disease or impaired kidney function, and patients with decreased liver function should use this medication with caution. Various side effects, such as dizziness, headache, hypotension, edema, indigestion, and rash may occur, so any abnormal symptoms should be discussed with a physician immediately. In particular, if blood pressure drops too low or heartbeats become irregular, appropriate treatment is needed. This medication may interact with other drugs, so it is important to inform your doctor or pharmacist of any other medications you are taking. If this drug is taken during pregnancy, it may pose a risk to the fetus, so stop taking it immediately if pregnancy is confirmed and consult a healthcare provider. Nursing women should discontinue breastfeeding or stop taking this medication, as it may be transmitted through breast milk and affect the baby. It is recommended that children under 18 years of age not take this medication as its safety and efficacy have not been established. Elderly patients should adjust the dosage and be monitored closely due to a slower metabolism of the drug caused by decreased kidney and liver function. In cases of overdose, severe hypotension and heart rhythm abnormalities may occur, requiring immediate medical attention. This medication should be stored in a tightly sealed container away from direct sunlight and moisture, and transferring it to another container should be avoided.
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to prevent exposure to air and moisture. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius. This helps to preserve the effectiveness of the medication.
Brownish-red round film-coated tablet
30 tablets (10 tablets/Alu-Alu x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 13.888mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 13.888mg
Tablet · Prescription medication · Combination
Hanmi Daiichi Sankyo Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
Co., Ltd. Sainex
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.